CCL1 released from M2b macrophages is essentially required for the maintenance of their properties

Journal of Leukocyte Biology

Volumn 92, Issue 4, 2012, Pages 859-867

  Asai, Akira ^a   Nakamura, Kiwamu ^a   Kobayashi, Makiko ^a,b   Herndon, David N ^b   Suzuki, Fujio ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Burn; CCL1; M2b macrophages; MRSA

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CCL1 CHEMOKINE; CXCL13 CHEMOKINE; INTERLEUKIN 10; MESSENGER RNA; THYMUS AND ACTIVATION REGULATED CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL GROWTH; BURN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; INFECTION SENSITIVITY; MACROPHAGE; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME;

ANIMALS; BURNS; CHEMOKINE CCL1; INTERLEUKIN-10; MACROPHAGES; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; OLIGORIBONUCLEOTIDES, ANTISENSE; STAPHYLOCOCCAL INFECTIONS;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS;

EID: 84868088824     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0212107     Document Type: Article

References (41)

1. Davey, V. (2002) Immunocompromised persons and emerging infectious diseases. In Emerging Infectious Diseases (F. R. Lashley, J. D. Durham, eds.), Springer, New York, NY, USA, 303-324.
2. Church, D., Elsayed, S., Reid, O., Winston, B., Lindsay, R. (2003) Burn wound infections. Clin. Microbiol. Rev. 19, 403-434.
3. Sheridan, R. L. (2005) Sepsis in pediatric burn patients. Pediatr. Crit. Care Med. 6, S112-S119.
4. Weber, J., McManus, A. (2004) Infection control in burn patients. Burns 30, A16-A24.
5. Vostrugina, K., Gudaviciene, D., Vitkauskiene, A. (2006) Bacteremias in patients with severe burn trauma. Medicina 42, 576-579.
6. Herndon, D. N. (2007) Total Burn Care, 3rd Ed. Saunders Elsevier, Philadelphia, PA, USA.
7. Bang, R. L., Gang, R. K., Sanyal, S. C., Mokaddas, E., Ebrahim, M. K. (1998) Burn septicaemia: an analysis of 79 patients. Burns 24, 354-361.
8. Wolf, S. E., Rose, J. K., Desai, M. H., Mileski, J. P., Barrow, R. E., Herndon, D. N. (1997) Mortality determinants in massive pediatric burns. An analysis of 103 children with > or ' 80% TBSA burns (> or ' 70% full-thickness). Ann. Surg. 225, 554-565.
9. Haddadin, A. S., Fappiano, S. A., Lipsett, P. A. (2002) Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad. Med. J. 78, 385-392.
10. Medzhitov, R., Janeway Jr., C. A. (1997) Innate immunity: impact on the adaptive immune response. Curr. Opin. Immunol. 9, 4-9.
11. Akira, S., Uematsu, S., Takeuchi, O. (2006) Pathogen recognition and innate immunity. Cell 124, 783-801.
12. Sebbane, F., Lemaitre, N., Sturdevant, D. E., Rebeil, R., Virtaneva, K., Porcella, S. F., Hinnebusch, B. J. (2006) Adaptive response of Yersinia pestis to extracellular effectors of innate immunity during bubonic plague. Proc. Natl. Acad. Sci. USA 103, 11766-11771.
13. Rothfuchs, A. G., Gigliotti, D., Palmblad, K., Andersson, U., Wigzell, H., Rottenberg, M. E. (2001) IFN-α/β-dependent, IFN-γ secretion by bone marrow-derived macrophages controls an intracellular bacterial infection. J. Immunol. 167, 6453-6461.
14. Rosenberger, C. M., Finlay, B. B. (2003) Phagocyte sabotage: disruption of macrophage signalling by bacterial pathogens. Nat. Rev. Mol. Cell. Biol. 4, 385-396.
15. Tanaka, H., Miyazaki, S., Sumiyama, Y., Kakiuchi, Y. (2004) Role of macrophages in a mouse model of postoperative MRSA enteritis. J. Surg. Res. 118, 114-121.
16. Sester, D. P., Stacey, K. J., Sweet, M. J., Beasley, S. J., Cronau, S. L., Hume, D. L. (1999) The actions of bacterial DNA on murine macrophages. J. Leukoc. Biol. 66, 542-548.
17. Gordon, S. (2003) Alternative activation of macrophages. Nat. Rev. Immunol. 3, 23-35.
18. Mosser, D. M. (2003) The many faces of macrophage activation. J. Leukoc. Biol. 73, 209-212.
19. Goldstein, E., Bartlema, H. C. (1977) Role of the alveolar macrophage in pulmonary bacterial defense. Bull. Eur. Physiopathol. Respir. 13, 57-67.
20. Vazquez-Torres, A., Jones-Carson, J., Mastroeni, P., Ischiropoulos, H., Fang, F. C. (2000) Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192, 227-236.
21. Itoh, Shibayama, N. H., Kanekiyo, M., Namphung, D., Nakanishi, T., Matsuyama, A., Odani, T., Tanaka, K. (2005) Reduced bactericidal activity and nitric oxide production in metallothionein-deficient macrophages in response to lipopolysaccharide stimulation. Toxicology 216, 188-196.
22. Rosenberger, C. M., Gallo, R. L., Finlay, B. B. (2004) Interplay between antibacterial effectors: a macrophage antimicrobial peptide impairs intracellular Salmonella replication. Proc. Natl. Acad. Sci. USA 101, 2422-2427.
23. Brogden, K. A. (2005) Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nat. Rev. Microbiol. 3, 238-250.
24. Punturieri, A., Alviani, R. S., Polak, T., Copper, P., Sonstein, J., Curtis, J. L. (2004) Specific engagement of TLR4 or TLR3 does not lead to IFN-γ-mediated innate signal amplification and STAT1 phosphorylation in resident murine alveolar macrophages. J. Immunol. 173, 1033-1042.
25. Zhu, Y. N., Yang, Y. F., Ono, S., Zhong, X. G., Feng, Y. H., Ren, Y. X., Ni, J., Fu, Y. F., Tang, W., Zuo, J. P. (2006) Differential expression of inducible nitric oxide synthase and IL-12 between peritoneal and splenic macrophages stimulated with LPS plus IFN-γ is associated with the activation of extracellular signal-related kinase. Int. Immunol. 18, 981-990.
26. Katakura, T., Yoshida, T., Kobayashi, M., Herndon, D. N., Suzuki, F. (2005) Immunological control of methicillin-resistant Staphylococcus aureus (MRSA) infection in an immunodeficient murine model of thermal injuries. Clin. Exp. Immunol. 142, 419-425.
27. Katakura, T., Miyazaki, M., Kobayashi, M., Herndon, D. N., Suzuki, F. (2004) CCL17 and IL-10 as effectors that enable alternatively activated macrophages to inhibit the generation of classically activated macrophages. J. Immunol. 172, 1407-1413.
28. Mantovani, A., Sica, A., Sozzani, S., Allavena, P., Vecchi, A., Locati, M. (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677-686.
29. high regulatory phenotype in macrophages. J. Immunol. 185, 2044-2050.
30. Martinez, F. O., Gordon, S., Locati, M., Mantovani, A. (2006) Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303-7311.
31. Sironi, M., Martinez, F. O., D'Ambrosio, D., Gattorno, M., Polentarutti, N., Locati, M., Gregorio, A., Iellem, A., Cassatella, M. A., Van Damme, J., Sozzani, S., Martini, A., Sinigaglia, F., Vecchi, A., Mantovani, A. (2006) Differential regulation of chemokine production by Fcγ receptor engagement in human monocytes: association of CCL1 with a distinct form of M2 monocyte activation (M2b, type 2). J. Leukoc. Biol. 80, 342-349.
32. Edwards, J. P., Zhang, X., Frauwirth, K. A., Mosser, D. M. (2006) Biochemical and functional characterization of three activated macrophage populations. J. Leukoc. Biol. 80, 1298-1307.
33. Shigematsu, K., Asai, A., Kobayashi, M., Herndon, D. N., Suzuki, F. (2009) Enterococcus faecalis translocation in mice with severe burn injury: a pathogenic role of CCL2 and alternatively activated macrophages (M2aMΦ and M2cMΦ). J. Leukoc. Biol. 86, 999-1005.
34. Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., Suzuki, F. (2004) Three different neutrophil subsets exhibited in mice with different susceptibilities to infection by methicillin-resistant Staphylococcus aureus. Immunity 21, 215-226.
35. Engelich, G., Wright, D. G., Hartshorn, K. L. (2001) Acquired disorders of phagocyte function complicating medical and surgical illnesses. Clin. Infect. Dis. 33, 2040-2048.
36. Schwacha, M. G. (2003) Macrophages and post-burn immune dysfunction. Burns 29, 1-14.
37. Göebel, A., Kavanagh, E., Lyons, A., Saporoschetz, I. B., Soberg, C., Lederer, J. A., Mannick, J. A., Rodrick, M. L. (2000) Injury induces deficient interleukin-12 production, but interleukin-12 therapy after injury restores resistance to infection. Ann. Surg. 231, 253-261.
38. Kobayashi, M., Jeschke, M. G., Shigematsu, K., Asai, A., Yoshida, S., Herndon, D. N., Suzuki, F. (2010) M2b monocytes predominated in peripheral blood of severely burned patients. J. Immunol. 185, 7174-7179.
39. Paterson, H. M., Murphy, T. J., Purcell, E. J., Shelley, O., Kriynovich, S. J., Lien, E., Mannick, J. A., Lederer, J. A. (2003) Injury primes the innate immune system for enhanced Toll-like receptor reactivity. J. Immunol. 171, 1473-1483.
40. Maung, A. A., Fujimi, S., Miller, M. L., MacConmara, M. P., Mannick, J. A., Lederer, A. (2005) Enhanced TLR4 reactivity following injury is mediated by increased p38 activation. J. Leukoc. Biol. 78, 565-573.
41. Matsukawa, A., Kudoh, S., Sano, G., Maeda, T., Ito, T., Lukacs, N. W., Hogaboam, C. M., Kunkel, S. L., Lira, S. A. (2006) Absence of CC chemokine receptor 8 enhances innate immunity during septic peritonitis. FASEB J. 20, 302-304.